Logo

Daiichi Sankyo

Thermo Fisher Scientific, Daiichi Sankyo Partner to Develop Non-Small Cell Lung Cancer CDx

The assay will identify patients with mutations in HER2 who may be eligible for treatment with a HER2-directed antibody-drug-conjugate developed by Daiichi.

ERS Genomics Licenses CRISPR-Cas9 IP to Daiichi Sankyo

Daiichi Sankyo plans to use the ERS IP to support its own R&D initiatives to address areas of unmet medical need, the company said.

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

The LeukoStrat CDx FLT3 Mutation Assay can now be used in Japan as the CDx for quizartinib for the treatment of FLT3-ITD positive relapsed or refractory AML.

Invivoscribe Submits FLT3 Mutation CDx Assay to FDA

Invivoscribe submitted the LeukoStrat CDx FLT3 Mutation Assay as a companion diagnostic for Daiichi Sankyo's acute myeloid leukemia drug quizartinib.

Invivoscribe Submits FLT3 Mutation Assay CDx to Japanese Regulators

The company submitted the test to Japanese regulators for approval as a companion diagnostic for Daiichi Sankyo's acute myeloid leukemia drug quizartinib.

May 1, 2018

Thermo Fisher Inks New Pharma Partnerships to Expand CDx Use of Oncomine NGS Test

Apr 17, 2017

HTG Molecular Inks Agreements With Daiichi Sankyo, Centre Léon Bérard

Apr 25, 2016

MolecularMD Gets CE Mark for CDx Assay Used in Daiichi Sankyo Clinical Trial

Mar 10, 2015

Study Provides 'Strong Evidence' Backing Warfarin Initiation PGx Testing; Adoption Impact Unclear
Premium

Apr 24, 2014

Agendia, Daiichi Sankyo Collaborate on Drug Assessment

Feb 3, 2012

KineMed Inks Deal with Pfizer to Use Dynamic Proteomics Platform in Diabetes Drug Development
Premium

Aug 25, 2011

Roche Launches Melanoma Companion Dx in EU After FDA OK Last Week
Premium

Aug 17, 2011

FDA Simultaneously Approves Roche/Plexxikon's Drug, Companion Dx for BRAF-Mutated Melanoma
Premium

Aug 17, 2011

FDA Approves Roche's Companion Dx and Drug for Melanoma

Jul 1, 2011

Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
Premium

May 18, 2011

Plexxikon, Roche File Rx/Dx Application for PLX4032, Cobas Mutation Test in Metastatic Melanoma
Premium

Mar 18, 2011

Kinaxo, Takeda Ink Second Collaboration for Phosphoproteomics Research
Premium

Jan 7, 2011

AstraZeneca Taps Kinaxo to Conduct Mass Spec PTM Studies for Oncology Drug Development
Premium

Sep 29, 2010

Kinaxo Inks Screening Deal with Daiichi Sankyo

Sep 2, 2010

New Data on CYP2C19 Loss-of-Function Alleles Questions Impact of Plavix PGx Testing
Premium

Jul 28, 2010

Medco to Compare Effient vs. PGx-Guided Plavix in Heart Patients on Prevacid
Premium

Oct 23, 2009

Morphosys, Daiichi Sankyo to Develop Therapeutic Antibodies Against Hospital-Acquired Infections
Premium

Oct 21, 2009

Medco Study to Gauge Whether PGx-Based Plavix Dosing is as Effective as Higher-Priced Effient
Premium

Mar 25, 2009

Gene Bridges Inks License with Japanese Pharma Firm

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.